Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: opioid

FDA Approves 2 Pain Drugs & New Gout Treatment on Road to Approval

Michele B. Kaufman, PharmD, BCGP  |  November 18, 2015

The FDA has approved two drugs designed to manage pain: buprenorphine for chronic pain and meloxicam capsules for OA pain. Lesurinad is also closer to FDA approval for treating gout…

Filed under:AnalgesicsBiologics/DMARDsDrug Updates

Rheumatologist Steven S. Overman Reflects on His Last Day of Practice, Future of Specialty

Steven S. Overman, MD, MPH • illustrations by Alice C. Gray  |  November 16, 2015

I am a few weeks post-retirement. Having written thank you notes and completed urgent home projects, I swing in a hammock at our currently fire-threatened cabin north of Winthrop, Wash., and reflect. I feel like a young boy while freely flipping pages of a hand-scribed picture book, The Principles of Uncertainty, by Maira Kalman. She…

Filed under:Practice SupportProfiles Tagged with:Profileretirementrheumatologistrheumatology practice

FDA Warns ‘Don’t Use Tramadol in Children’ & More

Michele B. Kaufman, PharmD, BCGP  |  October 21, 2015

New studies show ABT-494 is an effective alternative to anti-TNF alpha agents, as well as methotrexate, for RA. Also, the FDA issued a warning against using tramadol for young patients due to their increased risk of respiratory side effects…

Filed under:Drug Updates

Ustekinumab Can Be Used to Safely Treat Teens & More

Michele B. Kaufman, PharmD, BCGP  |  October 7, 2015

A recent study showed ustekinumab can be used to treat teens with moderate to severe psoriasis. Also, Phase 2 trials for an analgesic combination drug show it holds promise for reducing post-operative pain…

Filed under:AnalgesicsBiologics/DMARDsDrug Updates Tagged with:AdolescentsanalgesicBiologics & BiosimilarsPainustekinumab

Rituximab for RA Is Safe Long Term, Plus Oxycodone Update

Michele B. Kaufman, PharmD, BCGP  |  September 30, 2015

Rituximab was evaluated and found safe as a long-term RA therapy. Also, FDA Advisory Committees voted on oxycodone therapies at a joint meeting.

Filed under:AnalgesicsBiologics/DMARDsDrug Updates Tagged with:analgesicFDAFood and Drug AdministrationOxycodoneRheumatoid Arthritis (RA)rituximab

Ankle Replacement: Are Patients with Ankle Arthritis Good Candidates?

Linda Childers  |  September 15, 2015

Ankle arthritis is a debilitating condition that leaves many patients in severe pain and greatly limits their activities. Until recently, the standard treatment for bone-on-bone ankle pain has been ankle fusion, or arthrodesis, in which surgeons literally fuse the bones of the ankle joint together. However, in the past few years, total ankle replacement surgery,…

Filed under:ConditionsRheumatoid Arthritis Tagged with:ankle replacementpatient careRheumatoid arthritisTAAtotal ankle arthroplastyTreatment

Biosimilar for Infliximab Launched in Europe

Michele B. Kaufman, PharmD, BCGP  |  April 1, 2015

Plus, updates on arhalofenate, ALO-02, and other rheumatology drug news, safety information

Filed under:Biologics/DMARDsDrug Updates Tagged with:BiosimilarsDrugsFDAinfliximabKaufmanrheumatologySafety

Certolizumab Pegol Drug Studies Find No New Safety Issues

Michele B. Kaufman, PharmD, BCGP  |  March 1, 2015

Plus, updates on clazakizumab, hydrocodone bitartrate extended-release capsules and other rheumatology drug news, safety information

Filed under:Drug Updates Tagged with:Certolizumab PegolclazakizumabdrugFDAhydrocodone bitartrateKaufmanrheumatologySafety

Drug Interactions for Trimethoprim/ Sulfamethoxazole Come to Light

Michele B. Kaufman, PharmD, BCGP  |  February 1, 2015

Plus, updates on buprenorphine, diclofenac sodium, secukinumab and other rheumatology drug news, safety information

Filed under:AnalgesicsDrug Updates Tagged with:drugFDAinteractionKaufmanrheumatologySafety

2014 ACR/ARHP Annual Meeting: Rheumatology Drug Updates, Safety News

Michele B. Kaufman, PharmD, BCGP  |  January 1, 2015

Plus, hydrocodone combination products and brodalumab

Filed under:Biologics/DMARDsConditionsDrug UpdatesGout and Crystalline ArthritisMeeting Reports Tagged with:2014 ACR/ARHP Annual MeetingbrodalumabFDAhydrocodoneKaufmanrheumatologySafety

  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 32
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences